Group One Trading’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-91,300
| Closed | -$9.74M | – | 9252 |
|
|
2025
Q3 | $9.74M | Sell |
91,300
-38,500
| -30% | -$4.02M | 0.02% | 919 |
|
|
2025
Q2 | $12.3M | Sell |
129,800
-89,900
| -41% | -$6.66M | 0.03% | 682 |
|
|
2025
Q1 | $13.9M | Buy |
219,700
+140,900
| +179% | +$8.43M | 0.04% | 462 |
|
|
2024
Q4 | $3.66M | Buy |
78,800
+4,300
| +6% | +$161K | 0.01% | 1397 |
|
|
2024
Q3 | $2.14M | Sell |
74,500
-55,300
| -43% | -$1.36M | 0.01% | 1662 |
|
|
2024
Q2 | $1.88M | Buy |
129,800
+124,600
| +2,396% | +$1.82M | 0.01% | 1501 |
|
|
2024
Q1 | $83.7K | Sell |
5,200
-20,000
| -79% | -$346K | ﹤0.01% | 4296 |
|
|
2023
Q4 | $501K | Buy |
25,200
+11,300
| +81% | +$167K | ﹤0.01% | 3068 |
|
|
2023
Q3 | $227K | Buy |
13,900
+5,400
| +64% | +$104K | ﹤0.01% | 3697 |
|
|
2023
Q2 | $180K | Sell |
8,500
-19,000
| -69% | -$405K | ﹤0.01% | 4057 |
|
|
2023
Q1 | $552K | Sell |
27,500
-60,700
| -69% | -$1.31M | ﹤0.01% | 2679 |
|
|
2022
Q4 | $2.3M | Buy |
88,200
+75,800
| +611% | +$1.01M | 0.01% | 1707 |
|
|
2022
Q3 | $127K | Buy |
+12,400
| New | +$105K | ﹤0.01% | 4556 |
|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$5K | – | 8593 |
|
|
2022
Q1 | $5K | Buy |
+1,000
| New | +$5.82K | ﹤0.01% | 7482 |
|
Other funds holding VRNA
Group One Trading's VRNA Position: Q4 2024 in Review
Group One Trading sold out of Verona Pharma (VRNA) in Q4 2024, closing a stake of 49,577 shares — an estimated $1.86M sold.
Group One Trading first reported a position in VRNA in Q4 2021 and held it in 11 quarters. The position peaked at $1.43M in Q3 2024. 191 funds tracked by Wall St. Rank hold VRNA as of Q4 2024.
- Group One Trading reported no remaining Verona Pharma position as of Q4 2024 after selling out during the quarter.
- Group One Trading sold 49,577 Verona Pharma shares in Q4 2024, an estimated $1.86M.
- Group One Trading first reported a position in Verona Pharma in Q4 2021 and held it in 11 quarters.
- Group One Trading's Verona Pharma position peaked at $1.43M in Q3 2024.
- 191 funds tracked by Wall St. Rank held Verona Pharma as of Q4 2024.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.